tradingkey.logo

Teleflex Inc

TFX

116.375USD

+0.485+0.42%
交易中 美东报价延迟15分钟
5.14B总市值
34.43市盈率 TTM

Teleflex Inc

116.375

+0.485+0.42%
关于 Teleflex Inc 公司
Teleflex Incorporated 是一家全球医疗技术产品供应商。该公司主要设计、开发、制造和供应一次性医疗设备,供医院和医疗保健提供商用于重症监护和外科应用中的常见诊断和治疗程序。该公司有四个部门:美洲、EMEA(欧洲、中东和非洲)、亚洲(亚太地区)和 OEM(原始设备制造商和开发服务)。OEM 部门为其他医疗设备制造商设计、制造和供应设备和仪器。其 OEM 部门包括 TFX Medical OEM、TFX OEM、Deknatel 和 HPC Medical 品牌,提供定制挤压件、微直径薄膜铸造管、诊断和介入导管、球囊和球囊导管、薄膜绝缘细线、涂层芯轴线、导体、护套/扩张器导入器等。其其他品牌包括 Arrow、LMA、Pilling、QuikClot、Rusch、UroLift、Weck 和 Barrigel。
公司简介
公司代码TFX
公司名称Teleflex Inc
上市日期Mar 17, 1980
CEOMr. Liam J. Kelly
员工数量14100
证券类型Ordinary Share
年结日Mar 17
公司地址550 E Swedesford Rd
城市WAYNE
上市交易所NYSE Consolidated
国家United States of America
邮编19087
电话16102256800
网址https://www.teleflex.com/usa/en/#
公司代码TFX
上市日期Mar 17, 1980
CEOMr. Liam J. Kelly
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
49.49K
+19.61%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
9.22K
+12.86%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
5.54K
+23.40%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.16K
+25.60%
Mr. John C. Heinmiller
Mr. John C. Heinmiller
Independent Director
Independent Director
4.39K
+31.47%
Ms. Neena M. Patil, J.D.
Ms. Neena M. Patil, J.D.
Independent Director
Independent Director
1.98K
+113.50%
Dr. Jaewon Ryu, M.D., J.D.
Dr. Jaewon Ryu, M.D., J.D.
Independent Director
Independent Director
1.58K
+199.43%
Mr. John R. Deren
Mr. John R. Deren
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
49.49K
+19.61%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
9.22K
+12.86%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
5.54K
+23.40%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.16K
+25.60%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Vascular access
182.37M
26.03%
Interventional
137.56M
19.63%
Surgical
105.78M
15.10%
Anesthesia
86.59M
12.36%
Interventional urology
70.97M
10.13%
Other
117.40M
16.75%
地区USD
名称
营收
占比
Americas
475.72M
67.90%
EMEA
151.16M
21.57%
Asia Pacific
73.79M
10.53%
业务
地区
业务USD
名称
营收
占比
Vascular access
182.37M
26.03%
Interventional
137.56M
19.63%
Surgical
105.78M
15.10%
Anesthesia
86.59M
12.36%
Interventional urology
70.97M
10.13%
Other
117.40M
16.75%
股东统计
更新时间: 7月26日 周六
更新时间: 7月26日 周六
持股股东
股东类型
持股股东
持股股东
占比
T. Rowe Price Investment Management, Inc.
14.07%
BlackRock Institutional Trust Company, N.A.
12.12%
The Vanguard Group, Inc.
11.47%
Janus Henderson Investors
9.79%
UBS Financial Services, Inc.
7.50%
Other
45.06%
持股股东
持股股东
占比
T. Rowe Price Investment Management, Inc.
14.07%
BlackRock Institutional Trust Company, N.A.
12.12%
The Vanguard Group, Inc.
11.47%
Janus Henderson Investors
9.79%
UBS Financial Services, Inc.
7.50%
Other
45.06%
股东类型
持股股东
占比
Investment Advisor
67.05%
Investment Advisor/Hedge Fund
28.93%
Hedge Fund
7.40%
Research Firm
2.30%
Pension Fund
1.73%
Sovereign Wealth Fund
1.38%
Bank and Trust
0.40%
Individual Investor
0.33%
Family Office
0.09%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
1156
48.39M
109.50%
-826.33K
2025Q1
1189
48.85M
110.52%
-721.30K
2024Q4
1180
47.47M
102.37%
-260.40K
2024Q3
1150
46.34M
98.36%
-1.83M
2024Q2
1147
46.98M
99.75%
-268.09K
2024Q1
1153
46.02M
97.70%
-1.89M
2023Q4
1170
46.05M
97.91%
-2.57M
2023Q3
1173
45.95M
97.77%
-3.19M
2023Q2
1201
46.87M
99.79%
-2.79M
2023Q1
1212
46.93M
99.93%
-1.70M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
T. Rowe Price Investment Management, Inc.
6.22M
14.07%
+43.64K
+0.71%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
5.36M
12.12%
+2.71M
+102.18%
Mar 31, 2025
The Vanguard Group, Inc.
5.07M
11.47%
-456.07K
-8.26%
Mar 31, 2025
Janus Henderson Investors
4.33M
9.79%
-933.48K
-17.75%
Mar 31, 2025
UBS Financial Services, Inc.
3.31M
7.5%
+3.09M
+1413.63%
Mar 31, 2025
Atlanta Capital Management Company, L.L.C.
2.78M
6.29%
+73.14K
+2.70%
Mar 31, 2025
State Street Global Advisors (US)
1.53M
3.46%
-531.22K
-25.79%
Mar 31, 2025
Cooke & Bieler, L.P.
1.06M
2.39%
-21.03K
-1.95%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.02M
2.31%
-119.68K
-10.51%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
867.86K
1.96%
+355.72K
+69.46%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Invesco S&P SmallCap Health Care ETF
3.74%
SPDR S&P Health Care Equipment ETF
1.76%
First Trust Indxx Medical Devices ETF
1.67%
Distillate Small/Mid Cash Flow ETF
0.99%
SPDR S&P 600 Small Cap Value ETF
0.82%
iShares S&P Small-Cap 600 Value ETF
0.82%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.75%
VictoryShares Small Cap Free Cash Flow ETF
0.68%
iShares U.S. Medical Devices ETF
0.59%
SPDR S&P SmallCap 600 ESG ETF
0.55%
查看更多
Invesco S&P SmallCap Health Care ETF
占比3.74%
SPDR S&P Health Care Equipment ETF
占比1.76%
First Trust Indxx Medical Devices ETF
占比1.67%
Distillate Small/Mid Cash Flow ETF
占比0.99%
SPDR S&P 600 Small Cap Value ETF
占比0.82%
iShares S&P Small-Cap 600 Value ETF
占比0.82%
iShares MSCI USA Small-Cap Min Vol Factor ETF
占比0.75%
VictoryShares Small Cap Free Cash Flow ETF
占比0.68%
iShares U.S. Medical Devices ETF
占比0.59%
SPDR S&P SmallCap 600 ESG ETF
占比0.55%
分红派息
近5年累计派现 318.10M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Feb 27, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 17, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 17, 2025
Mar 07, 2025
Oct 31, 2024
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 16, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Dec 16, 2024
Nov 15, 2024
Aug 01, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 16, 2024 going ex on Aug 15, 2024
Aug 15, 2024
Sep 16, 2024
Aug 15, 2024
May 06, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 14, 2024 going ex on May 14, 2024
May 15, 2024
Jun 14, 2024
May 14, 2024
Feb 22, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 02, 2023
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2023 going ex on Nov 14, 2023
Nov 15, 2023
Dec 15, 2023
Nov 14, 2023
Aug 03, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2023 going ex on Aug 14, 2023
Aug 15, 2023
Sep 15, 2023
Aug 14, 2023
May 08, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 15, 2023 going ex on May 12, 2023
May 15, 2023
Jun 15, 2023
May 12, 2023
Feb 23, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 15, 2023 going ex on Mar 02, 2023
Mar 03, 2023
Mar 15, 2023
Mar 02, 2023
Oct 27, 2022
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2022 going ex on Nov 14, 2022
Nov 15, 2022
Dec 15, 2022
Nov 14, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
KeyAI